COMPAGNIE EUROPEENNE DE DISTRIBUTION PHARMACEUTIQUE
0501.544.636 · rovalta.com · 27/09/2026
ACTIVE
COMPAGNIE EUROPEENNE DE DISTRIBUTION PHARMACEUTIQUE
Financial year 2024 · Closed on 31/12/2024
Net result0 €+100,0 %over 1 year
Gross margin0 €+100,0 %over 1 year
Equity-64,4 k €0,0 %over 1 year
Overview
Identity
Source · BCE/KBOCOMPAGNIE EUROPEENNE DE DISTRIBUTION PHARMACEUTIQUE is a Public limited company incorporated in 2012. Its registered office is in Berchem-Sainte-Agathe.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0501.544.636
- Incorporation
- 26/11/2012
- Legal form
- Public limited company
- Registered office
- Rue Kasterlinden 128
1082 Berchem-Sainte-Agathe · BruxellesSee on map - Contributed capital
- 61 500,00 €
- Latest accounts
- 31/12/2024
Financials
Source · NBB, 9 filingsTrend over 9 financial years
| 2024 | 2022 | 2019 | 2018 | 2017 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 0 € | +100% | -175,2 € | +85.8% | -1,2 k € | -99.7% | -620 € | +75.0% | -2,5 k € |
| EBITDA | 0 € | +100% | -522,7 € | +67.0% | -1,6 k € | +63.8% | -4,4 k € | -12.9% | -3,9 k € |
| Operating result | 0 € | +100% | -522,7 € | +67.0% | -1,6 k € | +63.8% | -4,4 k € | -12.9% | -3,9 k € |
| Net result | 0 € | +100% | -1 k € | +38.5% | -1,6 k € | +63.7% | -4,5 k € | -14.8% | -3,9 k € |
| Balance sheet | |||||||||
| Equity | -64,4 k € | 0.0% | -64,4 k € | +3.7% | -66,9 k € | -2.5% | -65,3 k € | -7.4% | -60,8 k € |
| Total assets | 8,9 k € | 0.0% | 8,9 k € | -86.6% | 66,4 k € | -2.6% | 68,2 k € | -7.4% | 73,6 k € |
| Cash | 8,9 k € | 0.0% | 8,9 k € | -26.0% | 12 k € | -13.6% | 13,9 k € | -17.3% | 16,8 k € |
| Debts | 73,3 k € | 0.0% | 73,3 k € | -45.0% | 133,3 k € | -0.1% | 133,4 k € | -0.7% | 134,3 k € |
Board of directors
Source · NBB, accounts to 31/12/20192 active · 2 ended
Last known composition, from the accounts closed on 31/12/2019, more than two years before the latest accounts. The mandates shown may have expired.
Active mandates
Jean METZ
ActiveJean-Christophe METZ
ActiveEnded mandates
Jean METZ
EndedJean-Christophe METZ
EndedOther companies at this address
Rue Kasterlinden 128 1082 Berchem-Sainte-Agathe| Company | CBE no. |
|---|---|
ATELIER RELIEF● Active | 0560.791.345 |
CECHO accounting● Active | 0883.319.315 |
COMPPASS● Active | 0739.586.891 |
FRANCIRENE● Active | 0416.263.325 |
KANOPE CONSULTING SCS● Active | 0821.769.152 |
XL VISION● Active | 0740.693.681 |
Financials
Full financial information
Source · NBB| 2024 | 2022 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2024 | 01/01/2022 | 01/01/2019 | 01/01/2018 | 01/01/2017 | 01/01/2016 |
| Closing of the financial year | 31/12/2024 | 31/12/2022 | 31/12/2019 | 31/12/2018 | 31/12/2017 | 31/12/2016 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 31/08/2025 | 01/09/2023 | 30/11/2020 | 31/08/2019 | 31/08/2018 | 30/09/2017 |
| General meeting | 30/06/2025 | 30/06/2023 | 08/09/2020 | 28/06/2019 | 29/06/2018 | 30/06/2017 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 9 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2024 | 30/06/2025 | 31/08/2025 | French | |
| Micro model | 31/12/2022 | 30/06/2023 | 01/09/2023 | French | |
| Micro model | 31/12/2019 | 08/09/2020 | 30/11/2020 | French | |
| Micro model | 31/12/2018 | 28/06/2019 | 31/08/2019 | French | |
| Micro model | 31/12/2017 | 29/06/2018 | 31/08/2018 | French | |
| Micro model | 31/12/2016 | 30/06/2017 | 30/09/2017 | French | |
| Abridged model | 31/12/2015 | 24/06/2016 | 31/08/2016 | French | |
| Abridged model | 31/12/2014 | 02/06/2015 | 09/06/2015 | French | |
| Full model | 31/12/2013 | 27/06/2014 | 11/07/2014 | French |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20192 active · 2 ended
Last known composition, from the accounts closed on 31/12/2019, more than two years before the latest accounts. The mandates shown may have expired.
Active mandates
Jean METZ
ActiveJean-Christophe METZ
ActiveEnded mandates
Jean METZ
EndedJean-Christophe METZ
EndedOwnership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 20240 €↑
- 2024Name changeCEDIPHARM
- 2022Annual accounts 2022-1 k €↑
- 2022Name changeCOMPAGNIE EUROPEENNE DE DISTRIBUTION PHARMACEUTIQUE
- 2019Annual accounts 2019-1,6 k €↑
- 2018Annual accounts 2018-4,5 k €↓
- 2017Annual accounts 2017-3,9 k €↑
- 2016Annual accounts 2016-23,3 k €↓
- 2015Annual accounts 2015-6 k €↑
- 2014Annual accounts 2014-35,4 k €↑
- 2013Annual accounts 2013-53,7 k €
- 26/11/2012IncorporationPublic limited company